MITECH Obtains FDA Approval for HANAROSTENT Esophagus Asymmetric Product

[Asia Economy Reporter Minji Lee] MI Tech announced on the 19th that HANAROSTENT Esophagus Asymmetric has obtained product approval from the U.S. Food and Drug Administration (FDA).

This product is a stent used to alleviate malignant strictures and to occlude esophageal fistulas in the esophagus. The company explained, "With official export to the United States now possible, we can proceed with export sales to the U.S. and other overseas countries in accordance with relevant laws and regulations."

This content was produced with the assistance of AI translation services.